Pulmonary vein isolation alone in patients with persistent atrial fibrillation: An ablation strategy facilitated by antiarrhythmic drug induced reverse remodeling

Journal of Cardiovascular Electrophysiology

Volumn 22, Issue 2, 2011, Pages 142-148

  Khan, Aslam ^a   Mittal, Suneet ^a   Kamath, Ganesh S ^a   Garikipati, Naga Vamsi ^a   Marrero, Daniel ^a   Steinberg, Jonathan S ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

ablation; antiarrhythmic drug; dofetilide; electrical remodeling; P wave duration; persistent atrial fibrillation; pulmonary vein isolation

Indexed keywords

DOFETILIDE;

ABLATION THERAPY; ADULT; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPOTHESIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; P WAVE; PREDICTION; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; CHRONIC DISEASE; COMBINED MODALITY THERAPY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PHENETHYLAMINES; PULMONARY VEINS; SULFONAMIDES; TREATMENT OUTCOME;

EID: 79951642257     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01886.x     Document Type: Article

References (34)

1. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ,: HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007; 4: 816-861. (Pubitemid 46850611)
2. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J,: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666. (Pubitemid 28402090)
3. Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S, Scharf C, Lai SW, Greenstein R, Pelosi F Jr, Strickberger SA, Morady F,: Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105: 1077-1081. (Pubitemid 34212617)
4. Oral H, Chugh A, Lemola K, Cheung P, Hall B, Good E, Han J, Tamirisa K, Bogun F, Pelosi F Jr, Morady F,: Noninducibility of atrial fibrillation as an end point of left atrial circumferential ablation for paroxysmal atrial fibrillation: A randomized study. Circulation 2004; 110: 2797-2801. (Pubitemid 39473600)
5. Haissaguerre M, Jais P, Shah DC, Arentz T, Kalusche D, Takahashi A, Garrigue S, Hocini M, Peng JT, Clementy J,: Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers. J Cardiovasc Electrophysiol 2000; 11: 2-10. (Pubitemid 30080935)
6. Kanagaratnam L, Tomassoni G, Schweikert R, Pavia S, Bash D, Beheiry S, Lesh M, Niebauer M, Saliba W, Chung M, Tchou P, Natale A,: Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: Long-term follow-up. Pacing Clin Electrophysiol 2001; 24: 1774-1779. (Pubitemid 34066782)
7. Willems S, Klemm H, Rostock T, Brandstrup B, Ventura R, Steven D, Risius T, Lutomsky B, Meinertz T,: Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: A prospective randomized comparison. Eur Heart J 2006; 27: 2871-2878. (Pubitemid 44871470)
8. Hocini M, Sanders P, Jais P, Hsu LF, Takahashi Y, Rotter M, Clementy J, Haissaguerre M,: Techniques for curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15: 1467-1471. (Pubitemid 40013684)
9. Veenhuyzen GD, Knecht S, O'Neill MD, Wright M, Nault I, Rukshen W, Miyazaki S, Sacher F, Hocini M, Jais P, Haissaguerre M,: Atrial tachycardias encountered during and after catheter ablation for atrial fibrillation: Part I: classification, incidence, management. Pacing Clin Electrophysiol 2009; 32: 393-398.
10. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA,: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-1968.
11. Morillo CA, Klein GJ, Jones DL, Guiraudon CM,: Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995; 91: 1588-1595.
12. Allessie M, Ausma J, Schotten U,: Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002; 54: 230-246. (Pubitemid 34327903)
13. Moe GK, Abildskov JA,: Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959; 58: 59-70.
14. George Wyse D,: Reversal of remodeling in atrial fibrillation: A positive double-negative? J Cardiovasc Electrophysiol 2004; 15: 513-514.
15. Chalfoun N, Harnick D, Pe E, Undavia M, Mehta D, Gomes JA,: Reverse electrical remodeling of the atria post cardioversion in patients who remain in sinus rhythm assessed by signal averaging of the P-wave. Pacing Clin Electrophysiol 2007; 30: 502-509. (Pubitemid 46596127)
16. Raitt MH, Kusumoto W, Giraud G, McAnulty JH,: Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15: 507-512. (Pubitemid 38621898)
17. Khan A, Choi A, Musat D, Bangalore S, Badheka A, Mittal S, Steinberg J, Maleki K,: Predicting pulmonary vein isolation responders by using P wave duration on surface ECG. Heart Rhythm 2007; 4: S137.
18. Herweg B, Sichrovsky T, Polosajian L, Vloka M, Rozenshtein A, Steinberg JS,: Anatomic substrate, procedural results, and clinical outcome of ultrasound-guided left atrial-pulmonary vein disconnection for treatment of atrial fibrillation. Am J Cardiol 2005; 95: 871-875. (Pubitemid 40386802)
19. Arentz T, von Rosenthal J, Blum T, Stockinger J, Burkle G, Weber R, Jander N, Neumann FJ, Kalusche D,: Feasibility and safety of pulmonary vein isolation using a new mapping and navigation system in patients with refractory atrial fibrillation. Circulation 2003; 108: 2484-2490. (Pubitemid 37444410)
20. Singh SM, D'Avila A, Kim SJ, Houghtaling C, Dukkipati SR, Reddy VY,: Intraprocedural use of ibutilide to organize and guide ablation of complex fractionated atrial electrograms: Preliminary assessment of a modified step-wise approach to ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 608-616.
21. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE, Toutouzas PK,: Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998; 135: 733-738. (Pubitemid 28237295)
22. Aytemir K, Ozer N, Atalar E, Sade E, Aksoyek S, Ovunc K, Oto A, Ozmen F, Kes S,: P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000; 23: 1109-1112. (Pubitemid 30480158)
23. Kumagai K, Akimitsu S, Kawahira K, Kawanami F, Yamanouchi Y, Hiroki T, Arakawa K,: Electrophysiological properties in chronic lone atrial fibrillation. Circulation 1991; 84: 1662-1668.
24. Budeus M, Wieneke H, Sack S, Erbel R, Perings C,: Long-term outcome after cardioversion of atrial fibrillation: Prediction of recurrence with P wave signal averaged ECG and chemoreflexsensitivity. Int J Cardiol 2006; 112: 308-315. (Pubitemid 44415059)
25. Fukunami M, Yamada T, Ohmori M, Kumagai K, Umemoto K, Sakai A, Kondoh N, Minamino T, Hoki N,: Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation 1991; 83: 162-169.
26. Andrikopoulos GK, Dilaveris PE, Richter DJ, Gialafos EJ, Synetos AG, Gialafos JE,: Increased variance of P wave duration on the electrocardiogram distinguishes patients with idiopathic paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000; 23: 1127-1132. (Pubitemid 30480161)
27. Yigit Z, Akdur H, Ersanli M, Okcun B, Guven O,: The effect of exercise to P wave dispersion and its evaluation as a predictor of atrial fibrillation. Ann Noninvasive Electrocardiol 2003; 8: 308-312. (Pubitemid 38569967)
28. Greenbaum RA, Campbell TJ, Channer KS, Dalrymple HW, Kingma JH, Santini M,: Conversion of atrial fibrillation and maintenance of sinus rhythm by dofetilide. The EMERALD Study. Circulation 1998; 98: I-633.
29. Torp-Pedersen C, Moller M, Bloch-Thomsen PE, Kober L, Sandoe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm AJ,: Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999; 341: 857-865. (Pubitemid 29427047)
30. Prystowsky EN, Freeland S, Branyas NA, Rardon DP, Fogel RI, Padanilam BJ, Rippy JS,: Clinical experience with dofetilide in the treatment of patients with atrial fibrillation. J Cardiovasc Electrophysiol 2003; 14: S287-S290. (Pubitemid 38037457)
31. Cotiga D, Arshad A, Aziz E, Joshi S, Koneru JN, Steinberg JS,: Acute conversion of persistent atrial fibrillation during dofetilide initiation. Pacing Clin Electrophysiol 2007; 30: 1527-1530. (Pubitemid 350198266)
32. Kamath GS, Cotiga D, Musat D, Kabbli G, Aziz E, Enciso JS, Khan A, Mittal S, Steinberg JS,: Is there any value to initiating dofetilide after sotalol has failed to control atrial fibrillation? Heart Rhythm 2009; 6: S147.
33. Gwilt M, Arrowsmith JE, Blackburn KJ, Burges RA, Cross PE, Dalrymple HW, Higgins AJ,: UK-68,798: A novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells. J Pharmacol Exp Ther 1991; 256: 318-324.
34. Sedgwick ML, Rasmussen HS, Cobbe SM,: Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris. Am J Cardiol 1992; 69: 513-517.